Simplify Logo

Full-Time

Supervisor

Cls Tih

Posted on 6/28/2024

Natera

Natera

1,001-5,000 employees

Biotechnology firm specializing in genetic testing

Biotechnology
Healthcare

Compensation Overview

$98k - $140kAnnually

Mid, Senior

San Carlos, CA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • BS/BA degree in Medical Technology program with 4 years CLIA laboratory experience
  • BS/BA, Physical, Chemical or Biological Sciences, or a related field with 5 years experience in a CLIA laboratory
  • Master’s degree in arts or science with a major in chemical, physical or biological sciences with 3 years experience in a CLIA laboratory
  • Master’s degree with BS/BA in Medical Technology program with 2 years experience in a CLIA laboratory
Responsibilities
  • Staffing/scheduling/sample run schedules
  • Ensuring production work meets department goals
  • Processing and accounting for case samples
  • Monitoring team adherence to SOPs and safety procedures
  • Training new hires
  • Documenting nonconformance reports and corrective actions
  • Assisting in CAPAs
  • Handling employee issues
  • Ensuring compliance with regulatory agency requirements
  • Approving timecards and PTO requests
  • Escalating lab issues to manager
  • Identifying and troubleshooting lab issues
  • Interacting with interdepartmental teams
  • Providing direction to employees
  • Administering company policies
  • Completing side projects
  • Actively involved in meeting schedules and resolving problems

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care through accurate genetic insights and early detection of health issues.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

9%

1 year growth

19%

2 year growth

58%
Simplify Jobs

Simplify's Take

What believers are saying

  • Natera's continuous innovation, such as the launch of the Prospera Heart test with DQS, demonstrates its commitment to improving patient outcomes and maintaining market leadership.
  • The company's diverse product offerings across oncology, transplant health, and women's health provide multiple revenue streams and reduce dependency on a single market.
  • Significant investments from entities like Massachusetts Financial Services Co. MA indicate strong financial backing and confidence in Natera's growth potential.

What critics are saying

  • Allegations of deceptive sales and billing practices could damage Natera's reputation and lead to legal and financial repercussions.
  • The highly competitive nature of the genetic testing market requires constant innovation and differentiation to maintain market share.

What makes Natera unique

  • Natera's focus on cell-free DNA (cfDNA) technology for a wide range of applications, from oncology to prenatal screening, sets it apart from competitors who may specialize in only one area.
  • The introduction of unique features like the Donor Quantity Score (DQS) for transplant rejection detection enhances the accuracy and reliability of their tests, distinguishing them from other genetic testing companies.
  • Natera's extensive portfolio of over 200 peer-reviewed publications underscores its commitment to scientific validation and credibility, which is a significant competitive advantage.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

INACTIVE